Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep | 29 | 2023 | 4184 | 4.050 |
Why?
|
| Workplace | 7 | 2022 | 844 | 3.130 |
Why?
|
| Occupational Health | 5 | 2022 | 831 | 2.020 |
Why?
|
| Health Promotion | 10 | 2022 | 2208 | 1.960 |
Why?
|
| Health Communication | 3 | 2019 | 210 | 1.540 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 4 | 2023 | 927 | 1.450 |
Why?
|
| Automobile Driving | 2 | 2022 | 412 | 1.220 |
Why?
|
| Dementia | 3 | 2021 | 2259 | 0.970 |
Why?
|
| Administrative Personnel | 2 | 2016 | 184 | 0.960 |
Why?
|
| New York City | 8 | 2022 | 665 | 0.900 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2022 | 1684 | 0.780 |
Why?
|
| Caregivers | 4 | 2022 | 1925 | 0.680 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2022 | 3946 | 0.670 |
Why?
|
| Narration | 1 | 2019 | 205 | 0.610 |
Why?
|
| Hypertension | 4 | 2021 | 8270 | 0.610 |
Why?
|
| Internet | 6 | 2020 | 3071 | 0.590 |
Why?
|
| Students | 5 | 2023 | 1556 | 0.580 |
Why?
|
| Nutritional Sciences | 1 | 2016 | 141 | 0.550 |
Why?
|
| Polysomnography | 1 | 2022 | 1708 | 0.540 |
Why?
|
| Self Report | 3 | 2022 | 3409 | 0.510 |
Why?
|
| Burnout, Professional | 2 | 2020 | 636 | 0.510 |
Why?
|
| Persuasive Communication | 1 | 2014 | 66 | 0.490 |
Why?
|
| Awareness | 1 | 2018 | 600 | 0.490 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2016 | 273 | 0.480 |
Why?
|
| Language | 1 | 2021 | 1260 | 0.470 |
Why?
|
| Pandemics | 6 | 2022 | 7306 | 0.440 |
Why?
|
| Parents | 2 | 2022 | 3175 | 0.430 |
Why?
|
| Peer Group | 1 | 2017 | 634 | 0.430 |
Why?
|
| Focus Groups | 3 | 2022 | 1263 | 0.430 |
Why?
|
| Prostatic Neoplasms | 4 | 2022 | 10595 | 0.420 |
Why?
|
| Public Health | 3 | 2021 | 2430 | 0.410 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2018 | 869 | 0.390 |
Why?
|
| Health Behavior | 3 | 2022 | 2616 | 0.390 |
Why?
|
| Mothers | 1 | 2021 | 2021 | 0.390 |
Why?
|
| African Americans | 4 | 2021 | 4991 | 0.370 |
Why?
|
| Humans | 59 | 2023 | 715594 | 0.360 |
Why?
|
| Attitude to Health | 2 | 2016 | 2104 | 0.360 |
Why?
|
| Efficiency | 2 | 2022 | 493 | 0.340 |
Why?
|
| Communication | 2 | 2019 | 3501 | 0.330 |
Why?
|
| United States | 17 | 2022 | 67895 | 0.330 |
Why?
|
| Los Angeles | 3 | 2021 | 212 | 0.300 |
Why?
|
| Accidents, Traffic | 2 | 2022 | 803 | 0.290 |
Why?
|
| Program Evaluation | 3 | 2022 | 2538 | 0.290 |
Why?
|
| Male | 32 | 2023 | 350143 | 0.280 |
Why?
|
| Young Adult | 17 | 2023 | 56140 | 0.280 |
Why?
|
| Intention | 2 | 2019 | 310 | 0.270 |
Why?
|
| Consumer Health Information | 2 | 2018 | 217 | 0.270 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3312 | 0.270 |
Why?
|
| Female | 30 | 2023 | 377052 | 0.260 |
Why?
|
| Telemedicine | 1 | 2020 | 2608 | 0.240 |
Why?
|
| Adult | 20 | 2023 | 212237 | 0.230 |
Why?
|
| Aged | 16 | 2022 | 162392 | 0.230 |
Why?
|
| Adolescent | 14 | 2022 | 85064 | 0.220 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 7259 | 0.220 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 4884 | 0.210 |
Why?
|
| Health Policy | 1 | 2013 | 2650 | 0.200 |
Why?
|
| London | 1 | 2021 | 236 | 0.200 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 23385 | 0.190 |
Why?
|
| Residence Characteristics | 2 | 2021 | 1999 | 0.190 |
Why?
|
| Absenteeism | 1 | 2022 | 274 | 0.190 |
Why?
|
| Medicare | 3 | 2022 | 5786 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 1632 | 0.190 |
Why?
|
| Achievement | 1 | 2021 | 300 | 0.180 |
Why?
|
| Health Literacy | 2 | 2022 | 395 | 0.180 |
Why?
|
| Nurse Practitioners | 1 | 2022 | 269 | 0.170 |
Why?
|
| Quarantine | 1 | 2021 | 169 | 0.170 |
Why?
|
| Middle Aged | 15 | 2022 | 214639 | 0.170 |
Why?
|
| Sweden | 1 | 2021 | 1324 | 0.160 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3166 | 0.160 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2020 | 1510 | 0.160 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3283 | 0.160 |
Why?
|
| Communicable Disease Control | 2 | 2021 | 813 | 0.160 |
Why?
|
| Demography | 1 | 2022 | 1627 | 0.150 |
Why?
|
| Public Opinion | 1 | 2021 | 466 | 0.150 |
Why?
|
| Mother-Child Relations | 1 | 2021 | 496 | 0.150 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 13635 | 0.140 |
Why?
|
| Risk-Taking | 1 | 2021 | 997 | 0.140 |
Why?
|
| China | 1 | 2021 | 2234 | 0.140 |
Why?
|
| Employment | 1 | 2022 | 1102 | 0.130 |
Why?
|
| Suicidal Ideation | 2 | 2021 | 1110 | 0.130 |
Why?
|
| Sleep Deprivation | 1 | 2022 | 810 | 0.130 |
Why?
|
| Regression Analysis | 2 | 2016 | 6498 | 0.130 |
Why?
|
| Substance-Related Disorders | 2 | 2021 | 4182 | 0.130 |
Why?
|
| Universities | 2 | 2023 | 890 | 0.120 |
Why?
|
| Depression | 3 | 2022 | 7266 | 0.120 |
Why?
|
| Health Education | 2 | 2020 | 1067 | 0.120 |
Why?
|
| Video Recording | 1 | 2018 | 945 | 0.120 |
Why?
|
| Fatigue | 1 | 2020 | 1457 | 0.120 |
Why?
|
| Organizational Policy | 1 | 2016 | 439 | 0.120 |
Why?
|
| Computer-Assisted Instruction | 1 | 2016 | 377 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 727 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2021 | 51354 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 3 | 2020 | 4978 | 0.110 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2013 | 305 | 0.110 |
Why?
|
| Cities | 1 | 2013 | 499 | 0.100 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 1741 | 0.100 |
Why?
|
| New York | 1 | 2013 | 861 | 0.100 |
Why?
|
| Comprehension | 1 | 2016 | 605 | 0.100 |
Why?
|
| Mental Disorders | 2 | 2021 | 6445 | 0.100 |
Why?
|
| Anxiety | 2 | 2022 | 3912 | 0.100 |
Why?
|
| Time Factors | 4 | 2021 | 40889 | 0.100 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2015 | 353 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2018 | 2593 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2018 | 2502 | 0.100 |
Why?
|
| Mass Media | 1 | 2013 | 305 | 0.100 |
Why?
|
| Schools | 1 | 2019 | 1379 | 0.100 |
Why?
|
| Mental Recall | 1 | 2016 | 1194 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2018 | 1099 | 0.100 |
Why?
|
| Aniline Compounds | 1 | 2015 | 953 | 0.100 |
Why?
|
| Risk Factors | 4 | 2022 | 70931 | 0.090 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 2330 | 0.090 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 1044 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 2546 | 0.090 |
Why?
|
| Culture | 1 | 2014 | 641 | 0.090 |
Why?
|
| Nutrition Policy | 1 | 2013 | 469 | 0.090 |
Why?
|
| Life Style | 1 | 2021 | 3747 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2018 | 2550 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2022 | 8079 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1730 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 2941 | 0.080 |
Why?
|
| Prevalence | 3 | 2021 | 14877 | 0.080 |
Why?
|
| Australia | 2 | 2021 | 1325 | 0.080 |
Why?
|
| Pain | 1 | 2022 | 4693 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2018 | 2652 | 0.080 |
Why?
|
| Disease Management | 1 | 2018 | 2520 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2766 | 0.080 |
Why?
|
| Software | 1 | 2021 | 4392 | 0.070 |
Why?
|
| Primary Health Care | 2 | 2022 | 4523 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 2937 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2015 | 1923 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 58293 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2021 | 8534 | 0.070 |
Why?
|
| Quality of Life | 2 | 2022 | 11736 | 0.060 |
Why?
|
| Lung Neoplasms | 3 | 2016 | 12530 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7983 | 0.060 |
Why?
|
| Physicians | 1 | 2020 | 4371 | 0.060 |
Why?
|
| Exercise | 1 | 2019 | 5428 | 0.060 |
Why?
|
| Aging | 1 | 2021 | 8352 | 0.060 |
Why?
|
| Psychometrics | 2 | 2022 | 2972 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 3042 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2021 | 5623 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5407 | 0.050 |
Why?
|
| Organizations | 1 | 2022 | 167 | 0.050 |
Why?
|
| Knowledge | 1 | 2022 | 160 | 0.050 |
Why?
|
| Endocrine Cells | 1 | 2020 | 12 | 0.050 |
Why?
|
| Exocrine Glands | 1 | 2020 | 50 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2022 | 993 | 0.050 |
Why?
|
| Child | 4 | 2022 | 74413 | 0.040 |
Why?
|
| Geography | 1 | 2020 | 692 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2022 | 747 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 12268 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10285 | 0.040 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 118 | 0.040 |
Why?
|
| Social Isolation | 1 | 2020 | 335 | 0.040 |
Why?
|
| Mental Health | 2 | 2021 | 2681 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 16726 | 0.040 |
Why?
|
| Cognition | 1 | 2014 | 6074 | 0.040 |
Why?
|
| Sex Factors | 2 | 2020 | 10660 | 0.040 |
Why?
|
| Workload | 1 | 2022 | 856 | 0.040 |
Why?
|
| Neoplasms | 2 | 2015 | 20515 | 0.040 |
Why?
|
| Child Behavior | 1 | 2021 | 834 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 14439 | 0.030 |
Why?
|
| Prostate | 1 | 2022 | 1593 | 0.030 |
Why?
|
| Commerce | 1 | 2020 | 598 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2021 | 877 | 0.030 |
Why?
|
| Trust | 1 | 2018 | 492 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 459 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11238 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2015 | 635 | 0.030 |
Why?
|
| Athletes | 1 | 2021 | 1051 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9838 | 0.030 |
Why?
|
| Minority Groups | 1 | 2020 | 1088 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 1903 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1702 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2022 | 4903 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 877 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 2787 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 8560 | 0.030 |
Why?
|
| Morpholines | 1 | 2015 | 571 | 0.030 |
Why?
|
| Disease Progression | 2 | 2020 | 13219 | 0.030 |
Why?
|
| Social Support | 1 | 2021 | 2120 | 0.030 |
Why?
|
| Social Class | 1 | 2020 | 1975 | 0.030 |
Why?
|
| Health Surveys | 1 | 2021 | 4030 | 0.020 |
Why?
|
| Mice | 4 | 2020 | 80270 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2021 | 2544 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1116 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10600 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 2983 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 2030 | 0.020 |
Why?
|
| Remission Induction | 1 | 2015 | 2392 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2015 | 943 | 0.020 |
Why?
|
| Uncertainty | 1 | 2013 | 658 | 0.020 |
Why?
|
| Animals | 6 | 2020 | 169173 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3050 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 1156 | 0.020 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 6320 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6476 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1597 | 0.020 |
Why?
|
| Coenzyme A-Transferases | 1 | 1987 | 7 | 0.020 |
Why?
|
| Ketone Bodies | 1 | 1987 | 77 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3631 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 3683 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 2095 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2020 | 23705 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 16559 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 6092 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2015 | 2708 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 19529 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 5859 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 1987 | 512 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18772 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5190 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 11192 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4635 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 22636 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11664 | 0.010 |
Why?
|
| Neuroglia | 1 | 1987 | 920 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9494 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2015 | 19892 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18175 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 5914 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 41184 | 0.010 |
Why?
|
| Astrocytes | 1 | 1987 | 1233 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1987 | 1749 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9960 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2015 | 8028 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 29253 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1987 | 2963 | 0.010 |
Why?
|
| Glucose | 1 | 1987 | 4274 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 72448 | 0.010 |
Why?
|
| Sulfurtransferases | 1 | 1987 | 12 | 0.000 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 1987 | 57 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1987 | 2258 | 0.000 |
Why?
|
| Substrate Specificity | 1 | 1987 | 1822 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1987 | 2839 | 0.000 |
Why?
|
| Brain | 1 | 1987 | 25189 | 0.000 |
Why?
|
| Rats | 1 | 1987 | 24794 | 0.000 |
Why?
|
Concepts
(237)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_